Biosearch Technologies Takes License to the Roche 5' Nuclease Patents


Updated : Wed, October 1, 2014 @ 4:32 PM

Originally published : Thu, Oct 01, 2009 @ 07:08 AM

Biosearch Technologies has ground breaking news to announce today.  We licensed a family of patents covering practice of the 5' Nuclease process from Roche Molecular Systems (Roche). The Roche license provides freedom to operate, with respect to the Roche IP estate, for qPCR processes in the Diagnostic Research Field. This license makes Biosearch the first commercial oligonucleotide manufacturer to take the Roche license, which gives Biosearch the right to manufacture and sell dual-labeled probes for use in 5' Nuclease assays for internal research in the diagnostics field.

Click here to read the actual press release regarding Biosearch's licensing agreement with Roche Molecular Systems.

To learn about our services for the Molecular Diagnostics industry, visit our webpage, OUTSOURCE: Oligos for Molecular Diagnostics.


Leave a comment

Subscribe to our blog

About LGC, Biosearch Technologies

LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.

Posts by popularity

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!